PROMETH W/ DEXTROMETHORPHAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prometh W/ Dextromethorphan, and when can generic versions of Prometh W/ Dextromethorphan launch?
Prometh W/ Dextromethorphan is a drug marketed by G And W Labs Inc and is included in one NDA.
The generic ingredient in PROMETH W/ DEXTROMETHORPHAN is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.
Summary for PROMETH W/ DEXTROMETHORPHAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROMETH W/ DEXTROMETHORPHAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PROMETH W/ DEXTROMETHORPHAN
US Patents and Regulatory Information for PROMETH W/ DEXTROMETHORPHAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G And W Labs Inc | PROMETH W/ DEXTROMETHORPHAN | dextromethorphan hydrobromide; promethazine hydrochloride | SYRUP;ORAL | 088762-001 | Oct 31, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |